新兴的生物标志物和纳米生物感应策略在糖尿病中
Anupriya Baranwal1, Vipul Bansal1, Ravi Shukla1,2
1Sir Ian Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory, School of Science, RMIT University, Melbourne, VIC 3000, Australia.
Biosensors
|October 28, 2025
概括
通过使用先进的纳米生物传感器监测新的生物标志物,如microRNAs (miRNAs) 和adipokines,可以改善早期糖尿病诊断和管理. 这些技术提供了超越传统葡萄糖监测的灵敏,快速和最少侵入性的检测.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病是一种慢性代谢障碍,具有葡萄糖调节受损和严重的并发症.
- 目前的诊断依赖于葡萄糖监测,缺少早期的分子变化.
- 微RNA (miRNA) 和adipokine是新兴的生物标志物,具有诊断和预后价值.
研究的目的:
- 审查miRNAs和adipokines作为糖尿病生物标志物的临床相关性.
- 探索生物传感器技术的演变,以检测这些生物标志物.
- 分析纳米生物传感器应用在糖尿病管理中的挑战和未来方向.
主要方法:
- 关于糖尿病病理生理学,生物标志物 (miRNAs,adipokines) 和生物传感器技术的文献综述.
- 专注于纳米生物传感器的进步,以进行敏感和选择性检测.
- 对当前的研究,挑战和未来前景进行批判性分析.
主要成果:
- miRNAs和adipokines显示出作为糖尿病早期诊断和预后标记物的显著潜力.
- 纳米生物传感器能够对这些生物标志物进行高度敏感,选择性,快速和最小侵入性的检测.
- 技术进步正在扩大生物传感器的范围,超越葡萄糖监测.
结论:
- 通过纳米生物传感器监测miRNAs和adipokines的改变水平,可以导致早期糖尿病诊断和改善管理.
- 纳米技术驱动的生物传感器为下一代糖尿病诊断提供了一个有前途的平台.
- 进一步的研究和开发对于克服挑战和实现这些技术的全部潜力至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K


